Chinese
Japan
English
Home
Biologics Discovery
Antibody Lead Generation
Hybridoma Generation for Therapeutic Antibody Discovery
Single B Cell Screening
Fully Human Antibody Discovery by Transgenic Mice
Human Fab Naïve Library
Solution for Novel Biologics Modalities
Bispecific Antibody DiscoveryNEW!
Innovative SMABody Bispecific Antibody Discovery
CAR Lead Discovery
Single Domain Antibody Discovery
ADC Discovery Service
Antibody Lead Optimization
Antibody Humanization
Antibody Affinity Maturation
Fc Engineering Service
Developability Assessment
Pharmacology & Discovery Reagent Service
In Vitro Pharmacology
ADCC, CDC & ADCP Assay
GPCR-targeted Assay
Cytokine Neutralization Assay
Antibody Internalization Assay
Immune Checkpoint Reporter Assay
Immune Checkpoint Primary Cell Assay
Conventional Assay Cell Line Engineering Service
Customized Functional Reporter Assay Service
Bispecific Antibody Bioassay ServiceNEW!
Pseudovirus Neutralization Assay Services for SARS-CoV-2
In Vivo Pharmacology
In Vivo Efficacy
Pharmacokinetics Study
Toxicology Study
Biomarker testing and bioanalysis
Anti-idiotype Antibody and Immunoassay Development
PK and ADA Assay Development Services
Anti-idiotype antibody case study
Universal PK Tool Antibody Service for Antibody Drug
Affinity Measurement
Biologics CDMO
Stable Pool & Material Generation
Cell Line Development
ADCC Enhanced Cell Line Development
Host Cell Commercial License
GMP Cell Banking
IND-enabling CMC
Perfusion Process Development
CMC Case Study
Bioanalytical Development
ADCC & CDC Assays
Protein/Ab Characterization
SARS-CoV-2 Neutralizing Antibody In Vitro Bioassay Services
Bioassay Characterization NEW!
Drug Substance (DS) cGMP Manufacturing
Drug Product (DP) Aseptic Fill & Finish
Antibody & Protein CMC Solutions for CGT New!
ProBox™ Process Development Tool Box
CGT CDMO
Plasmid CDMO Services
LentiHelper™ Plasmid Products
AAssistV™ Plasmid Products
Plasmid CMC for IND
Plasmid Manufacture
GMPro™ Plasmid Manufacturing
Linearized DNA Manufacture
mRNA CDMO Service
mRNA CMC for IND
mRNA Manufacture
Lentiviral Vector CDMO Services
Cell Line for LVV Manufacturing
Cell Banking
ProLVV Manufacturing
Lentiviral Vector One-stop Solution
GMP LVV Manufacturing
AAV Vector CDMO Services
Cell Line for AAV Manufacturing
ProAAV Manufacturing Service
AAV One-stop Solution
AAV Manufacturing
News & Activities
GenScript-Thermo Fisher Strategic Partnership on Life Sciences and Biopharma
GenScript Biotech's Biologics R&D and Production Center is Formally Put Into Operation
China's Largest Plasmid and Virus Facility from GenScript was Put into Operation
ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony
Chinese CDMO GenScript starts construction of GenScript-Legend Biotech Commercial Manufacturing Center
GenScript and Selecxine Enter Into Strategic Cooperation Agreement
GenScript launches CDMO segment GenScript ProBio at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum
Beroni Group Signs Agreement with GenScript ProBio to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19
GenScript ProBio American Commercial Head, Kenneth Lee gives interview to The Medicine Maker about How we can help customers optimize their developing and manufacturing processes
GenScript ProBio Licensed Global Rights to Develop and Commercialize a SMAB Bispecific Antibody Molecule to REMD Biotherapeutics Inc.
GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program
GenScript ProBio Wins Bioprocessing Excellence in CDMO Services from IMAPAC
GenScript ProBio Chinese Brand Unveiled, CDMO Capacity Upgraded
Serving a Rising Power
Initium Therapeutics Strategically collaborates with GenScript ProBio
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology
SunRock Biopharma and GenScript ProBio Enter into a Collaboration Agreement to Develop Novel Monoclonal Antibody Program
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement
GenScript ProBio Congratulates EyeGene for Clinical Trial Approval for mRNA COVID-19 Vaccine in South Korea
GenScript ProBio Passed European Union Qualified Person (QP) Audit Successfully
GenScript ProBio and TG ImmunoPharma Enter into Collaboration on Innovative Antibody Drug Project
GenScript ProBio Named a Top 10 Drug Discovery Solution Provider in Asia-Pacific
China’s Largest Commercial GMP Plasmid Manufacturing Facility is Put into Operation, GenScript ProBio Expanding Manufacturing Capacity Again
GenScript ProBio and AbTis Enter into an Exclusive Worldwide License Agreement for ADC Targeting Claudin 18.2
Successful Groundbreaking Ceremony for GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector Manufacturing Facility in Zhenjiang, China
GenScript ProBio initiates a CDMO contract for next-generation CD47 antibody with InnoBation Bio
National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
GenScript ProBio Signs CDMO Supply Agreement And Forms Strategic Partnership with AffyXell Therapeutics – A Joint Daewong-Avacta Venture
Athenex Partners with Leading Contract Manufacturer GenScript ProBio in the Development of Advanced Cell and Gene Therapies
GenScript ProBio and ProteoNic BV Signed a Strategic Cooperation Based on High Expressing Vector System
GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies
GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program
GenScript ProBio Signs MOU to Form Strategic Partnership with GeneCraft To Development and Production of New AAV gene therapies
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) – the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new
GenScript ProBio Licenses Novel Fc Silencing Technology from mAbsolve
A bispecific antibody molecule jointly developed by Buchang Pharmaceutical and REMD Biotherapeutics，partners of GenScript ProBio, received IND clearance from NMPA for clinical trial
Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp
GenScript ProBio Congratulates Selecxine’s IND Clearance from MFDS
A Joint Collaboration Between Bio Immunitas and GenScript ProBio Leads to the Development and Fast Track Manufacturing of A Novel Therapeutic Platform
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
GenScript ProBio Congratulates Eutilex’s IND Clearance from MFDS
GenScript ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing
Resource Library
Handbooks
Webinars
Biologics Webinar Series
Our Heart Goes Out to You, Our Heroes in Combating COVID-19
Global Biologics and CGT Symposium 2023- South Korea
About Us
Management Team
Experience & Expertise
Careers
Partnership
Privacy Policy
Cookies Policy
Quality Management
Capabilities & Capacity
Regulatory Affairs
Locations
Voice of Customer
Site Map
GenScript ProBio - 日本語紹介